Highlights the role of interferon-gamma and TNF-alpha in enhancing PD-L1 in mesenchymal stem cells, suggesting new immunotherapy approaches.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: